ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 634353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 634353; 2) Community: the network communities that were significantly associated with the response to NSC 634353; 3) Molecule: the relationships between components within communities and NSC 634353; 4) MDR: the compounds that were significantly associated with the NSC 634353.

NSC Compound Enrichment Correlation
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.000184748296800011 0.78143577
NSC 620109 Propanoic acid, 3-bromo-2-(bromomethyl)-, methyl ester 0.000197378553434947 0.74616548
NSC 630599 Null 0.000197378553434947 0.60672792
NSC 636918 Null 0.000197378553434947 0.50370187
NSC 638636 Null 0.000197378553434947 0.66125991
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.000197378553434947 0.61092919
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.000197378553434947 0.55398535
NSC 150555 Afungin 0.000209886950886023 0.68213117
NSC 38643 Lenamycin 0.000209886950886023 0.64226065
NSC 624771 5H-Benzocyclohepten-5-one, 4-(acetyloxy)-6,6-dibromo- 6,7,8,9-tetrahydro- 0.000209886950886023 0.82364823
Total:149  Current:2    [First] [Prev] [Next] [Last]